Our study identified increased expression of many exosomal surface epitopes (CD19, CD8, CD69, and CD86) in IPF patients with respect to controls, suggesting that an alteration of these markers may be associated with lung fibrosis. This evidence concerns the gene CD19 and pulmonary fibrosis.